However, double knockdown tumors were about 30% (shRb-1/shCD44–2E) or 20% (shRb-2/shCD44–3E) lighter than Rb knockdown alone, suggesting that CD44 suppression has a strong impact on tumor growth in the context of Rb suppression. The gene discussed is RB1; the disease is neoplasm.